AdvaMedDx is the world’s largest association representing the industry’s leading in vitro diagnostic companies, in such key issues as the establishment of a risk-based approach to the regulation of in vitro diagnostics to support timely patient access to safe and effective tests, and the ongoing need to reform Medicare’s payment system in regards to fully recognizing the value of the newest advanced clinical laboratory diagnostic tests.
“We are happy and honored to join a key organization which gives us the opportunity to be involved in the discussion of such priority issues affecting our industry and patient access,” said Stephane Zamia, Chief Executive Officer of Diagnostica Stago, Inc., and Head of the All America Division of Stago. “There is no doubt that our commitment to the development and provision of the very best products and services in hemostasis will be enhanced by our ability to share a common voice and passion for the industry with AdvaMedDx members. We look forward to working with the membership and its mission to create a better understanding of the value of medical diagnostic tests and to improve patient outcomes.”
By joining and participating in AdvaMedDx, DSI will contribute to the ongoing discussions and issues affecting patient access to an effective and safe IVD technology including product innovation, FDA approval, reimbursement, international trade and many others.
About Diagnostica Stago, Inc.
Diagnostica Stago, Inc. is the exclusive provider of the Stago Hemostasis product lines in the United States and offers a complete system of coagulation instruments, optimized reagent kits for research as well as for routine analysis and services. Diagnostica Stago, Inc. is the U.S. subsidiary of Stago, S.A.S. France, a leader in the development and manufacture of Hemostasis products. For more information about any Stago product or service, please call 800-222-COAG or visit our website at www.stago-us.com.